Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.75 |
| ▸ | RHEB | Q15382 | 4/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9598311 | 0.86 | TDP1 (0.57) | TDP1RHEBF10RAB9ANPC1 | |
| SCHEMBL12636194 | 0.86 | TDP1 (1.00) | TDP1RHEBNPSR1F10RAB9A | |
| SCHEMBL485294 | 0.84 | TDP1 (0.53) | TDP1F10RAB9ANPC1GAA | |
| SCHEMBL18291859 | 0.82 | TDP1 (0.51) | TDP1F10RAB9ANPC1GAA | |
| SCHEMBL5100448 | 0.82 | TDP1 (0.51) | TDP1F10RAB9ANPC1GAA | |
| SCHEMBL7764723 | 0.82 | GAA (0.64) | TDP1F10RAB9ANPC1GAA | |
| SCHEMBL4151145 | 0.82 | TDP1 (0.51) | TDP1F10RAB9ANPC1GAA | |
| Hydrochloric Acid SCHEMBL4148629 | 0.81 | TDP1 (0.50) | TDP1F10RAB9ANPC1GAA | |
| Hydrochloric Acid SCHEMBL30012925 | 0.81 | TDP1 (0.50) | TDP1F10RAB9ANPC1GAA | |
| Hydrochloric Acid SCHEMBL5204712 | 0.81 | TDP1 (0.50) | TDP1F10RAB9ANPC1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138071-A1 | SULFIDE GAS REMOVAL PROCESS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-05-21 | — | — | US | disclosed |
| US-20260014517-A1 | HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014514-A1 | METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260014197-A1 | DRUG DELIVERY SYSTEM | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-01-15 | — | — | US | disclosed |
| US-20260008009-A1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-08 | — | — | US | disclosed |
| US-20260002088-A1 | PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-01-01 | — | — | US | disclosed |
| US-20250381514-A1 | METHOD FOR REMOVING HYDROGEN SULFIDE FROM SOUR GAS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-12-18 | — | — | US | disclosed |
| US-12459862-B2 | Cement paste composition | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-11-04 | — | — | US | disclosed |
| US-12427499-B2 | Process for removing hydrogen sulfide from sour gases | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-09-30 | — | — | US | disclosed |
| US-12415726-B2 | Process for simultaneous removal of hydrogen sulfide and heavy metals | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-09-16 | — | — | US | disclosed |
| EP-2094701-A2 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON, INC. (US) | 2009-09-02 | — | — | EP | disclosed |
| US-7504426-B2 | Heterocyclic compounds | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-03-17 | — | — | US | disclosed |
| US-20080221148-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC | 2008-09-11 | — | — | US | disclosed |
| WO-2008080001-A2 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008080015-A2 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| EP-1671972-A1 | Octahydropyrrolo[3,4-c]pyrrole derivatives | Pfizer Limited (GB) | 2006-06-21 | — | — | EP | disclosed |
| US-20060111416-A1 | Octahydropyrrolo[3,4-C]pyrrole derivatives | PFIZER INC. | 2006-05-25 | — | — | US | disclosed |
| EP-1545532-A2 | HETEROCYCLIC COMPOUNDS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-06-29 | — | — | EP | disclosed |
| US-20040058934-A1 | Heterocyclic compounds | JANSSEN PHARMACEUTIC, N.V. (BE) | 2004-03-25 | — | — | US | disclosed |
| WO-2004022060-A2 | (1H-BENZOIMIDAZOL-2-YL)-(PIPERAZINYL)-METHANONE DERIVATIVES AND RELATED COMPOUNDS AS HISTAMINE H4-RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2004-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008009-A1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION | HMOX2, HMOX1, SCO2 | TDP1 4784/4885RHEB 3453/4885NPSR1 1528/4885 |
| US-20260014517-A1 | HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION | TST, SOD1, SAMM50 | TDP1 3048/4885RHEB 3508/4885NPSR1 2018/4885 |
| US-20060111416-A1 | Octahydropyrrolo[3,4-C]pyrrole derivatives | DPYD, PAH, DHPS | TDP1 1015/4885RHEB 1525/4885NPSR1 331/4885 |
| US-20260002088-A1 | PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION | SAMM50, SOD1, HNRNPH3 | TDP1 4626/4885RHEB 3949/4885NPSR1 1511/4885 |
| US-20040058934-A1 | Heterocyclic compounds | HRH4, HRH2, HRH1 | TDP1 4329/4885RHEB 2027/4885NPSR1 157/4885 |
| US-20260138071-A1 | SULFIDE GAS REMOVAL PROCESS | SAMM50, SRSF1, GTF2F1 | TDP1 4119/4885RHEB 2718/4885NPSR1 2498/4885 |
| US-20080221148-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | MAP3K20, MAP3K13, MAP3K8 | TDP1 631/4885RHEB 567/4885NPSR1 4558/4885 |
| US-20260014514-A1 | METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR | SOD1, MAFG, HMOX2 | TDP1 4234/4885RHEB 4231/4885NPSR1 3431/4885 |
| US-20260014197-A1 | DRUG DELIVERY SYSTEM | IPO8, SLC39A11, SLC2A8 | TDP1 3457/4885RHEB 1237/4885NPSR1 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.